Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

SILK laser

  • Home
  •  
  • SILK laser



  • Most Read
  • Latest Comments
  • Bidding war intensifies: SILK receives competing acquisition offer from EC Healthcare
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Bidding war intensifies: SILK receives competing acquisition offer from EC Healthcare
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Bidding war intensifies: SILK receives competing acquisition offer from EC Healthcare
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Bidding war intensifies: SILK receives competing acquisition offer from EC Healthcare
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Bidding war intensifies: SILK receives competing acquisition offer from EC Healthcare
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • Bailador Technology sells telehealth platform InstantScripts to Wesfarmers for $135m
    Bailador Technology sells telehealth platform InstantScripts to Wesfarmers for $135m
    • News

  • Bidding war intensifies: SILK receives competing acquisition offer from EC Healthcare
    Bidding war intensifies: SILK receives competing acquisition offer from EC Healthcare
    • News

  • SILK Laser receives $169m Wesfarmers acquisition offer, shareholders voice support
    SILK Laser receives $169m Wesfarmers acquisition offer, shareholders voice support
    • News

  • Sigma takes on Wesfarmers in bidding war for Australian Pharmaceutical Industries, Priceline
    Sigma takes on Wesfarmers in bidding war for Australian Pharmaceutical Industries, Priceline
    • News

  • Bidding war intensifies: SILK receives competing acquisition offer from EC Healthcare
    • News

    Bidding war intensifies: SILK receives competing acquisition offer from EC Healthcare

    The beauty treatment company SILK Laser Australia (ASX: SLA) has found itself at the center of a bidding war as it contemplates the offers from two interested parties—EC Healthcare and Australian Pharmaceutical Industries (API). As if in an episode of the Bachelor, it must now decide: who gets the rose? SILK Laser Australia has received

    Read More
    Public
  • SILK Laser receives $169m Wesfarmers acquisition offer, shareholders voice support
    • News

    SILK Laser receives $169m Wesfarmers acquisition offer, shareholders voice support

    Australian conglomerate Wesfarmers (ASX: WES)—the company behind Bunnings, Kmart and Priceline—has set its sights on acquiring Silk Laser (ASX: SLA), a leading provider of skin treatment and laser hair removal services, for a whopping $169 million.  Wesfarmers’ subsidiary, Australian Pharmaceutical Industries (API), has entered into a Transaction Process Deed with SILK Laser Australia Limited in

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.